Burning Rock Biotech Limited (BNR) Misses Q2 EPS by RMB 1.20

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q2 EPS of (RMB2.50), RMB1.20 worse than the analyst estimate of (RMB1.30). Revenue for the quarter came in at RMB130.8 million versus the consensus estimate of RMB150.5 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings
• RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million